Director of the Institute of Cancer Research and Robert and Janet Perro Endowed Chair
The Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory
Northwell Health has formed a strategic partnership with the NCI-designated Cancer Center at Cold Spring Harbor Laboratory (CSHL). The institutions are deeply committed to fostering collaborations to transform basic science discoveries into new therapies.
The Feinstein Institutes for Medical Research (FIMR), with Cold Spring Harbor Laboratory (CSHL), now welcomes applications for the inaugural Director of FIMR's Institute of Cancer Research who will also serve as the Robert and Janet Perro Endowed Chair of Cancer Research at FIMR and a full Professor at CSHL.
The Director will be responsible for creating a unique and transformative basic and translational research program that fosters collaborations between FIMR, the Northwell Health Cancer Institute (NHCI) and CSHL. The Director will have the opportunity to recruit faculty, help identify needed resources, and shape the research directions of the Institute. At the same time, the Director will have an independent laboratory to continue pursuing personal research interests.
The ideal candidate will be a leading physician scientist with a track record of applying innovative ideas and diverse methodologies to foster and facilitate translational cancer research in a highly collaborative and interdisciplinary environment. Candidates from any area of translational cancer research are invited to apply including but not limited to theranostics, immunology/immunotherapy, cancer neuroscience/physiology, and precision oncology. The successful applicant will hold an MD or MD/PhD (or equivalent) and will be a scientific leader at an NCI-designated cancer center or academic research institute. This pivotal position will report directly to the President and CEO of FIMR and will work closely with the CSHL Cancer Center Director to identify collaborative projects, recruit, and build the capabilities needed to take full advantage of this unique strategic partnership.
The successful candidate will benefit from all the resources available to FIMR faculty, CSHL faculty, and CSHL Cancer Center members including innovative research core facilities and numerous scientific seminars, conferences, and courses at the internationally renowned CSHL. Both FIMR and CSHL have highly ranked graduate schools that train PhD students and vibrant postdoctoral communities that steadily attract talented early-career researchers.
FIMR and CSHL value diversity among their faculty and are committed to building a culturally diverse intellectual community that prioritizes best practices in mentorship, equity, and inclusion. We welcome applications from candidates of all genders, races, ethnicities, abilities, and identities. Candidates who have experience working with diverse groups of patients, faculty, staff, and students are encouraged to describe their experiences in their application materials.
About FIMR: The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider in New York State. Encompassing 50+ research labs, 3,000 clinical research studies, and 5,000 researchers and staff, FIMR raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research.
About Northwell Health Cancer Institute: Northwell Health is one of the largest cancer care providers in the New York metropolitan area, diagnosing 16,000 cases and treating over 19,000 patients annually. The mission of the Northwell Health Cancer Institute is to provide high-quality, comprehensive cancer care in a coordinated, multidisciplinary, and compassionate environment. The Cancer Institute has evolved from a sophisticated community setting into a "hybrid cancer center" that combines the best of academic and community cancer care, giving patients access to the services of more than 200 Cancer Institute physicians in more than 25 sub-specialties.
About the CSHL Cancer Center: Located on the North Shore of Long Island in New York, Cold Spring Harbor Laboratory is a world-renowned research and educational institution with cancer, neuroscience, plant biology, genomics, and quantitative biology research programs. NCI designated since 1987, the CSHL Cancer Center has broken new ground in basic tumor biology and developed innovative, advanced technologies for exploring the fundamental biology of human cancer. Research in the CSHL Cancer Center covers a broad range of cancer types including breast, prostate, leukemia, glioma, pancreatic, colon, endometrial, sarcoma, lung, and melanoma.
About the Northwell Health-CSHL affiliation: The affiliation between Northwell Health and CSHL combines mechanistic biology from CSHL's research discoveries with the highest level of health care from Northwell Health to accelerate cancer research, diagnosis, and treatment. Since 2015, the affiliation has launched education initiatives and training programs, expanded access to clinical trials, and provided funding for new investigations. Together, Northwell Health and CSHL are committed to bringing discoveries out of the lab and to patients so we can collectively identify new diagnostics and therapeutics that will more effectively treat cancer.
HOW TO APPLY
Please submit a cover letter/personal statement, curriculum vitae, NIH-style biosketch, and 3-5-page vision statement to Matthew Faber, Director, Office of Physician Recruitment, Northwell Health at . Letters of reference will be requested separately at a later stage.
The vision statement should describe your vision for the FIMR Institute of Cancer Research to develop multidisciplinary and collaborative research programs across Feinstein, Northwell Health Cancer Institute, and Cold Spring Harbor Laboratory. The statement should also describe your philosophy, experience, and contributions to topics such as equity in cancer research, inclusive mentoring, and scientific leadership, particularly as they apply to building translational research programs across diverse institutions and disciplines.
Applications will be accepted until the position is filled, with priority consideration given to those received by November 15 th , 2024. Additional scientific inquiries regarding the position should be directed to Ms. Kelly Lewis, CSHL Cancer Center Administrator at . All other inquiries regarding the search should be directed to Matthew Faber at .
Compensation will be nationally competitive. The successful applicant will receive a comprehensive start-up and benefits package that includes initial funding in addition to the base salary. The salary of the person selected will be determined by a variety of factors including but not limited to scope of role, level of experience, education, specialty/subspeciality, credentials, academic and research accomplishments, clinical and/or research productivity, quality metrics, patient experience, site/location internal equity, budget, and Fair Market Value evaluation.